Don't have an account? Register here to gain unlimited access to The Medicine Maker.
10/29/2020 | Stephanie Vine
Fujifilm Toyama's influenza treatment passes COVID-19 trial.
10/28/2020 | Maryam Mahdi
Exploring a new approach to treating IBS pain.
10/27/2020 | Maryam Mahdi
In what ways can the microbiome interact with oral medicines?
10/26/2020 | David Jones
QC must evolve to meet progress in biopharmaceutical manufacturing.
10/26/2020 | James Strachan
Looking back at Trump’s tenure, and the potential implications of the US elections for pharma and the Affordable Health Act.
10/24/2020 | Graeme Dennis
Graeme Dennis questions why the industry refuses to make use of the significant amount of data it generates.
10/23/2020 | Maryam Mahdi
How is African pharma coping with the COVID-19 pandemic?
10/22/2020 | Kelly Chibale
What can African nations do to retain the talent necessary for building pharmaceutical infrastructure?
10/21/2020 | Sarah Adam, Cyntia Genolet
Can the African Medicines Agency be mobilized quickly enough to respond to the needs of the pharmaceutical sector?
10/21/2020 | Sponsored by GenScript Probio
The gene and cell therapy market is growing, but does it have the CDMO support needed to maintain its upward trajectory?
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
The Intersection of Sustainability
Boosting Vaccine Stability with Gelatin
Let’s Make a Real Difference in Cancer